Retigabine瑞替加滨

ID：T2536

PURITY：0.98

Formula：C16H18FN3O2

MolWt：303.33

Appearance：白色粉末

Solubility：G410 mM in DMSO

Bioactivity：Ezogabine (D23129) is a close structural analog of the centrally acting analgesic flupitrine. It is a neuronal potassium channel opener being developed as a first-in-class antiepileptic drug (AED) and is currently being studied in Phase 3 trials as an adjunctive treatment for partial-onset seizures in adult patients with refractory epilepsy. FDA approved in June 10, 2011 under the name of ezogabine.

Status：

Pathways：Membrane Transporter/Ion Channel

Target：Potassium Channel

Receptor：Potassium Channel